Starpharma is using a Victorian Government voucher to diversify into new industries by exploring different applications of its existing core technology. The company already has a number of products under development in the health sector, and wanted to further advance its platform technology to improve the performance of crop protection products. The voucher enabled the company to further develop technology which in turn has led to several new commercial partnerships and to explore new commercial applications, positioning Starpharma to capture opportunities in the $40 billion crop protection market.
Starpharma Holdings Limited (ASX: SPL) is commercialising its platform dendrimer technology and recent progress has seen it included in the ASX300 index of leading Australian companies. Dendrimers are man-made, sophisticated molecules that can be useful in their own right or when used in combination with other compounds. For example, Starpharma’s technology offers advantages in the pharmaceutical space where the dendrimers can bind to drugs and biological compounds to enhance their performance.
Discover more about Starpharma Holdings Limited